Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/3/25 16:33 | 2/28/25 | LXRX | Health | Drug | Pharmaceutical Preparations | Alexander Kristen | TX | O | VP,Finan | 1 | M.d | 0 | 0.00 | 0 | 46 | 155 | 76 | D | ||||||||||||||
3/3/25 16:33 | 2/28/25 | LXRX | Health | Drug | Pharmaceutical Preparations | McDermott Wendy | TX | O | SVP,HR | 1 | M.d | 0 | 0.00 | 0 | 99 | 436 | 122 | D | ||||||||||||||
3/3/25 16:32 | 2/28/25 | LXRX | Health | Drug | Pharmaceutical Preparations | Main Alan J | TX | O | EVP,Inno | 1 | M.d | 0 | 0.00 | 0 | 127 | 60 | 339 | D | ||||||||||||||
3/3/25 16:31 | 2/28/25 | LXRX | Health | Drug | Pharmaceutical Preparations | Granowitz Craig B | TX | O | SVP,Chie | 1 | M.d | 0 | 0.00 | 0 | 138 | 120 | D | |||||||||||||||
3/3/25 16:30 | 2/28/25 | LXRX | Health | Drug | Pharmaceutical Preparations | Defrancesco Lisa | TX | O | SVP,IR,C | 1 | M.d | 0 | 0.00 | 0 | 25 | 16 | D | |||||||||||||||
3/3/25 16:28 | 2/28/25 | LXRX | Health | Drug | Pharmaceutical Preparations | Crum Brian T | TX | O | SVP,GC,S | 1 | M.d | 0 | 0.00 | 0 | 129 | 98 | 261 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |